We are live on
!
Find out more
AG
Algert Global Portfolio holdings
AUM
$6.65B
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
-1.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$2.13B
AUM Growth
-$171M
(-7.4%)
Cap. Flow
-$72.8M
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
4.9%
Holding
1,308
New
241
Increased
338
Reduced
415
Closed
223
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Driven Brands
DRVN
|
+$12.7M |
| 2 |
Clearway Energy Class C
CWEN
|
+$8.58M |
| 3 |
Group 1 Automotive
GPI
|
+$6.45M |
| 4 |
Vir Biotechnology
VIR
|
+$6.41M |
| 5 |
Itron
ITRI
|
+$6.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$9.94M |
| 2 |
Apple
AAPL
|
+$9.34M |
| 3 |
TriNet
TNET
|
+$9.02M |
| 4 |
WCC
WESCO International
WCC
|
+$8.13M |
| 5 |
ManpowerGroup
MAN
|
+$7.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.88% |
| 2 | Technology | 14.78% |
| 3 | Consumer Discretionary | 14.34% |
| 4 | Healthcare | 13.46% |
| 5 | Financials | 13.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Genius Sports
GENI
$1.73B
| $68K | ﹤0.01% |
+12,740
| New | +$84.4K |
|
|
KZR
1052
DELISTED
Kezar Life Sciences
KZR
| $68K | ﹤0.01% |
5,739
| – | – |
|
1053
Aurora
AUR
$11.7B
| $67K | ﹤0.01% |
+28,560
| New | +$88.5K |
|
1054
Compass Therapeutics
CMPX
$373M
| $67K | ﹤0.01% |
33,963
-54,870
| -62% | -$136K |
|
1055
Microvast
MVST
$267M
| $66K | ﹤0.01% |
+34,680
| New | +$74.3K |
|
1056
SelectQuote
SLQT
$114M
| $66K | ﹤0.01% |
56,710
-12,650
| -18% | -$19.1K |
|
1057
Stoke Therapeutics
STOK
$1.82B
| $65K | ﹤0.01% |
16,550
-18,298
| -53% | -$120K |
|
1058
Smart Sand
SND
$200M
| $64K | ﹤0.01% |
27,670
| – | – |
|
1059
Hudbay
HBM
$9.92B
| $63K | ﹤0.01% |
12,900
| – | – |
|
|
CONN
1060
DELISTED
Conn's Inc.
CONN
| $63K | ﹤0.01% |
15,890
-5,010
| -24% | -$20.8K |
|
1061
Black Diamond Therapeutics
BDTX
$101M
| $57K | ﹤0.01% |
+19,820
| New | +$73K |
|
1062
DHI Group
DHX
$166M
| $57K | ﹤0.01% |
18,552
-6,030
| -25% | -$21.5K |
|
1063
Kaltura
KLTR
$211M
| $57K | ﹤0.01% |
32,725
| – | – |
|
|
LONA
1064
LeonaBio Inc
LONA
$69.4M
| $56K | ﹤0.01% |
2,777
| – | – |
|
1065
Quad
QUAD
$430M
| $56K | ﹤0.01% |
11,052
-8,410
| -43% | -$44.1K |
|
1066
1stdibs.com
DIBS
$145M
| $54K | ﹤0.01% |
14,740
-2,620
| -15% | -$10.5K |
|
|
AAIC
1067
DELISTED
Arlington Asset Investment Corp.
AAIC
| $54K | ﹤0.01% |
12,704
-19,516
| -61% | -$88.5K |
|
1068
SGHC Ltd
SGHC
$7.3B
| $52K | ﹤0.01% |
+14,090
| New | +$46.7K |
|
1069
Apyx Medical
APYX
$165M
| $50K | ﹤0.01% |
+15,470
| New | +$72.1K |
|
1070
Lantronix
LTRX
$236M
| $50K | ﹤0.01% |
+11,240
| New | +$49.3K |
|
|
NOTV
1071
DELISTED
Inotiv
NOTV
| $46K | ﹤0.01% |
+14,960
| New | +$68.5K |
|
|
ITI
1072
DELISTED
Iteris, Inc.
ITI
| $45K | ﹤0.01% |
10,750
| – | – |
|
1073
Organogenesis Holdings
ORGO
$308M
| $43K | ﹤0.01% |
13,525
-10,680
| -44% | -$33.9K |
|
1074
Broadwind
BWEN
$113M
| $41K | ﹤0.01% |
12,735
| – | – |
|
|
NGM
1075
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $40K | ﹤0.01% |
37,390
-99,860
| -73% | -$207K |
|
Similar funds
TB
CI
MIP
AS
NMIMC
AACR
MSE
FLPIM
Algert Global's Q3 2023 Portfolio in Review
As of Q3 2023, Algert Global held 1,308 positions worth $2.13B, down 7.4% from $2.3B the previous quarter. Its ten largest holdings account for 4.9% of the portfolio.
Algert Global withdrew a net $72.8M in Q3 2023, closing 223 positions and reducing 415 holdings. Its most notable exit was Apple, an estimated $9.34M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Algert Global opened a new position in Driven Brands worth $8.72M.
- Algert Global's largest Q3 2023 buy was Driven Brands: 692,268 shares worth $8.72M.
- Algert Global added most to Clearway Energy Class C in Q3 2023, an estimated $8.58M increase.
- Algert Global's biggest Q3 2023 reduction was Manhattan Associates, cutting an estimated $9.94M.
- Algert Global fully exited Apple in Q3 2023, selling an estimated $9.34M.
- Algert Global's ten largest holdings make up 4.9% of its $2.13B portfolio in Q3 2023.
- Algert Global opened 241 new positions and closed 223 in Q3 2023.
- Algert Global's portfolio value fell 7.4% quarter-over-quarter to $2.13B.
Based on Algert Global's 13F filing for Q3 2023, filed 13 Nov 2023.